Compound Detail
CHEMBL4446463
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4446463 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AZBMKUCWLPFTGQ-UHFFFAOYSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
384.3
MW (Da)
4.71
ALogP
5
HBA
1
HBD
69.6
PSA (Ų)
0.52
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 4.86
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SU-DHL-8 CHEMBL4523562 | IC50 | 4.86 | 4.86 | 13690.0 | 1 |
| H9 CHEMBL614806 | IC50 | 4.66 | 4.66 | 22070.0 | 1 |
| FEPD CHEMBL614866 | IC50 | 4.6 | 4.6 | 24890.0 | 1 |
| DOHH-2 CHEMBL2366181 | IC50 | 4.56 | 4.56 | 27350.0 | 1 |
| Farage CHEMBL4483236 | IC50 | 4.51 | 4.51 | 30900.0 | 1 |
| HH CHEMBL2366310 | IC50 | 4.37 | 4.37 | 43120.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SU-DHL-8 | IC50 | = | 13690.0 | nM | 4.86 | Antiproliferative activity against human SUDHL8 cells assessed as reduction in c... | 31400706 |
| H9 | IC50 | = | 22070.0 | nM | 4.66 | Antiproliferative activity against human H9 cells assessed as reduction in cell ... | 31400706 |
| FEPD | IC50 | = | 24890.0 | nM | 4.6 | Antiproliferative activity against human FEPD cells assessed as reduction in cel... | 31400706 |
| DOHH-2 | IC50 | = | 27350.0 | nM | 4.56 | Antiproliferative activity against human DOHH2 cells assessed as reduction in ce... | 31400706 |
| Farage | IC50 | = | 30900.0 | nM | 4.51 | Antiproliferative activity against human Farage cells assessed as reduction in c... | 31400706 |
| HH | IC50 | = | 43120.0 | nM | 4.37 | Antiproliferative activity against human HH cells assessed as reduction in cell ... | 31400706 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31400706 | 10.1016/j.ejmech.2019.07.048 | DOHH-2 | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | Farage | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | SU-DHL-8 | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | SU-DHL-6 | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | HuT78 | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | FEPD | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | H9 | 1 |
| 31400706 | 10.1016/j.ejmech.2019.07.048 | HH | 1 |
Data from ChEMBL 36 via Core Engine